Friday | BioResearch Online
Intravenous COTI-2 In Combination With Doxil (Doxorubicin...
Critical Outcome Technologies Inc. , announced positive results today from combination agent animal experiments carried out at a prominent American cancer research facility.
Vegetarians are less likely to develop cancer than meat eaters, according to several newspapers.
UNCW nursing students try to raise scholarship money
UNCW nursing students are hosting a fundraiser to help aid the Kay Whitfield School of Nursing Endowed Scholarship.
European Urology July Issue Reviews Prostate Screening Studies
The July issue of European Urology , the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer with the results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial In the editorial, Professor ...
Ovarian cancer sufferers are 'dying unnecessarily' as doctors confuse symptoms with IBS
Lives may be lost because ovarian cancer is misunderstood and mistaken for bowel problems, a report said today.
Widespread Confusion About Ovarian Cancer Signs Says UK Charity
There is widespread confusion among women and doctors about the signs of ovarian cancer, said a UK charity behind a study being published today, Monday 29 June, at the House of Commons.
Ovary cancer signs 'confusion'
There is "widespread confusion" amongst doctors and women about ovarian cancer, a charity has said.
Some promising news on the health care front, specifically the fight against breast and ovarian cancer.
Platypus link to ovarian cancer
Researchers from the Royal Adelaide Hospital and University of Adelaide believe our oldest mammalian relative may help us to better understand ovarian cancer.
New Drug Targeting Cancer Weakness Shows Great Promise
Main Category: Breast Cancer Also Included In: Ovarian Cancer ; Prostate / Prostate Cancer ; Cancer / Oncology Article Date: 25 Jun 2009 - 4:00 PDT Scientists at The Institute of Cancer Research and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of ...
New Cancer Drug Fights Tumors in Those With BRCA Mutations
A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies.
Camp Good Days holds cancer summit
Cancer kills more than half a million people every year but to find a cure, doctors need to change the way the public looks at the disease.
Join Kelly Ripa To Fight Ovarian Cancer One Lemonade Glass at a Time
Talk show host Kelly Ripa has teamed up with Electrolux to fight ovarian cancer by inviting people to open up virtual lemonade stands online! It's a really cool concept of raising funds and awareness about ovarian cancer.
Sounding the alarm for early cancer testing
The video pulses with the Black Eyed Peas song "Boom Boom Pow" while the message flashes on screen: "Pay attention to your family history! Dying before 50 from cancer is NOT normal! ... Make your family history clear to your doctor! Yell at them!" Then a young woman appears, fit and sexy in a red sports bra, to tell you about her double mastectomy ...
Ovarian Cancer Breakthrough Pave New Hope For Personalized Cancer Treatment
Posted By fatjim2 8 hours, 35 minutes ago in News > After a successful research on cancer treatment, a group of doctors and scientists from Vancouver is set to receive international recognition.
Lawmakers Tout Legislation To Promote Breast Cancer Awareness Among Younger Women At High Risk
Legislation proposed in March would help make certain groups of women younger than age 40 aware of their elevated risk for breast cancer, Rep.
Cancer Treatment Centers of America(R) Studies Treatment That Aims...
The Phase II clinical study, called "PRECEDENT," is designed to evaluate the safety and efficacy of EC145, a drug currently being studied in the treatment for women with ovarian cancer who develop a resistance to standard platinum-based chemotherapy.
Woman who sought assisted suicide dies in Missoula
A Missoula woman, unable to find a physician willing to prescribe drugs that would hasten her death, has died of ovarian cancer.
OXiGENE Appoints Dr. Peter J. Langecker as Chief Development Officer
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced the appointment of Peter J. Langecker, M.D., Ph.D., as Executive Vice President and Chief Development Officer.
Relay for Life teams raise $12,000
EAST LANSING - Chad Camplease, 36, never realized the devastation cancer could create until his wife, Jennifer, was diagnosed with ovarian cancer in December 2007, just one day shy of her 32nd birthday.